Abstract:Objective To investigate the inhibition effects of CpG oligodeoxynucleotide(CpG ODN) on renal carcinoma cell proliferation and tumor growth in vivo and in vitro,and explore the possible mechanism.Methods The effects of different concentrations of CpG ODN1826 and non-CpG ODN1982(ODN1982) interventions on proliferation of human renal clear cell carcinoma cell line Caki-1 cultured in vitro were determined with CCK-8 method.Tumor-bearing nude mouse models were established by subcutaneous implantation of Caki-1 cells into 24 BALB/c mice,and were randomly divided into control group(PBS),ODN1982 group(50 μg ODN1982),low-dose CpG ODN1826 group(25 μg CpG ODN1826) and high-dose CpG ODN1826 group(50 μg CpG ODN1826) 4 d later according to means of weekly treatment,with 6 mice in each group.Mice were sacrificed 35 d after model establishment,and changes of tumor volumes,tumor weight and tumor histology were compared among groups.Splenic lymphocytes of tumor-bearing mice in each group were isolated in vitro,and lactate dehydrogenase release method was employed to detect the cytolytic activity of splenic lymphocytes of tumor-bearing mice to tumor cells with different effector/target ratios(splenic lymphocytes:Caki-1 cells or splenic lymphocytes:YAC-1 cells).Results ODN1982 had no significant effect on in vitro proliferation of Caki-1 cells,while 500 μg/mL CpG ODN1826 significantly inhibited proliferation of Caki-1 cells.The tumor volumes of low-dose CpG ODN1826 group and high-dose CpG ODN1826 group were significantly smaller than those of control group and ODN1982 group at the end point of experiment(P 0.05),and there were significant differences in tumor weight among groups(P 0.05).It was revealed by histological observations that there were more inflammatory cell infiltration in low-dose CpG ODN1826 group and high-dose CpG ODN1826 group.The cytolytic activity of splenic lymphocytes of mice in high-dose CpG ODN1826 group to Caki-1 cells and YAC-1 cells was(9.74 ± 1.16) % and(79.65 ± 5.23) %,respectively at effector/target ratio of 50:1,and was significantly higher than that in control group [(7.67 ± 0.22) % and(10.12 ± 3.03) %,respectively] and ODN1982 group [(7.66 ± 0.93) % and(27.60 ± 9.83) %,respectively](P 0.05).Conclusion CpG ODN can inhibit renal carcinoma cell proliferation in vitro and tumor growth in tumor-bearing nude mice,and the mechanism may relate to the enhancement of innate immunity by CpG ODN.

CpG-oligodeoxynucleotides may be effective for preventing ionizing radiation induced pulmonary fibrosis.

Effects of CpG Oligodeoxynucleotide 1826 on Transforming Growth Factor-Beta 1 and Radiation-Induced Pulmonary Fibrosis in Mice

The Effect of the TLR9 Ligand CpG-oligodeoxynucleotide on the Protective Immune Response to Radiation-Induced Lung Fibrosis in Mice.

Effects of CpG Oligodeoxynucleotide 1826 on Acute Radiation-Induced Lung Injury in Mice

Protection of CpG ODN 1826 Against Radiation Pulmonary Fibrosis in Rats

Ameliorating Effect of CpG-ODN (oligodeoxynucleotide) Against Radiation-Induced Lung Injury in Mice

Enhancing Radiosensitivity of Human Pulmonary Adenocarcinoma Cell Line A549 by Cpg Odn1826

Cytosine–phosphate–guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1/XRCC1 axis

Targeting Toll-Like Receptor 9 with CpG Oligodeoxynucleotides Enhances Anti-Tumor Responses of Peripheral Blood Mononuclear Cells from Human Lung Cancer Patients.

CpG Oligodeoxynucleotides Enhance the Efficacy of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes by Modifying the Th1 Polarization and Local Infiltration of Th17 Cells

In Vivo and in Vitro Study of Inhibition Effects of CpG Oligodeoxynucleotide on Renal Carcinoma Cell Proliferation and Tumor Growth

Cpg-Odn Attenuates Pathological Cardiac Hypertrophy And Heart Failure By Activation Of Pi3k Alpha-Akt Signaling

Cpg-Odn 7909 Increases Radiation Sensitivity of Radiation-Resistant Human Lung Adenocarcinoma Cell Line by Overexpression of Toll-Like Receptor 9

CpG ODN107 Potentiates Radiosensitivity of Human Glioma Cells Via TLR9-mediated NF-κB Activation and NO Production.

Advances in research on the treatment of non-small-cell lung cancer by unmethylated cytidine-phosphate-guanosine-containing oligodeoxynucleotides（CpG ODN）

Immunostimulatory and Anti-Neoplasm Effects of a Novel Palindrome CpG Oligodeoxynucleotide in Mice

Toll-like Receptor 9 Activation by CpG Oligodeoxynucleotideï¿½7909 Enhances the Radiosensitivity of A549 Lung Cancer Cells Via the P53 Signaling Pathway

Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice.

CpG-ODN enhances sensitivity to chemotherapy in lung cancer cell line A549

High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells.

CpG-PEG Conjugates and Their Immune Modulating Effects after Systemic Administration